Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (261-270 of 349) with videos related to

Pageof 35
Sort By:
Bioconjugate Chemistry|September 21, 2006
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agentsThomas D Harris, Shirley Kalogeropoulos, Tiffany Nguyen, et al.
Transfusion|February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimensCharles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2012
Cancer vaccines and T cell therapyKatayoun Rezvani, Joshua D Brody, Holbrook E Kohrt, et al.
Haematologica|December 3, 2011
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantationJan Joseph Melenhorst, Xin Tian, Dihua Xu, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Military Medicine|August 20, 2024
Development and Validation of the Veteran Military Occupational and Environmental Exposure Assessment ToolJohn Barrett, Immanuel Babu Henry Samuel, Charity Breneman, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Blood|June 28, 2003
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationKatayoun Rezvani, Matthias Grube, Jason M Brenchley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
Leukemia Research Reports|May 3, 2017
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemiaPrachi Jain, Jeffrey Klotz, Neil Dunavin, et al.
Pageof 35

Showing results (261-270 of 349) with videos related to

Sort By:
Pageof 35
Bioconjugate Chemistry|September 21, 2006
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agentsThomas D Harris, Shirley Kalogeropoulos, Tiffany Nguyen, et al.
Transfusion|February 14, 2004
Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimensCharles D Bolan, Yu Ying Yau, Herbert C Cullis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2012
Cancer vaccines and T cell therapyKatayoun Rezvani, Joshua D Brody, Holbrook E Kohrt, et al.
Haematologica|December 3, 2011
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantationJan Joseph Melenhorst, Xin Tian, Dihua Xu, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Military Medicine|August 20, 2024
Development and Validation of the Veteran Military Occupational and Environmental Exposure Assessment ToolJohn Barrett, Immanuel Babu Henry Samuel, Charity Breneman, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Blood|June 28, 2003
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationKatayoun Rezvani, Matthias Grube, Jason M Brenchley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
Leukemia Research Reports|May 3, 2017
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemiaPrachi Jain, Jeffrey Klotz, Neil Dunavin, et al.
Pageof 35